2-chloro-n(6)cyclopentyladenosine has been researched along with soman in 2 studies
Studies (2-chloro-n(6)cyclopentyladenosine) | Trials (2-chloro-n(6)cyclopentyladenosine) | Recent Studies (post-2010) (2-chloro-n(6)cyclopentyladenosine) | Studies (soman) | Trials (soman) | Recent Studies (post-2010) (soman) |
---|---|---|---|---|---|
252 | 0 | 43 | 1,391 | 4 | 257 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Langston, JL; Meads, KL; Myers, TM; Shih, TM; Thomas, TP | 1 |
Acon-Chen, C; Loughery, TN; Shih, TM; Whitten, KA | 1 |
2 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and soman
Article | Year |
---|---|
Evaluation of adenosine A1 receptor agonists as neuroprotective countermeasures against Soman intoxication in rats.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Anticonvulsants; Behavior, Animal; Brain; Deoxyadenosines; Disease Models, Animal; Male; Neuroprotective Agents; Organophosphate Poisoning; Rats, Sprague-Dawley; Receptor, Adenosine A1; Seizures; Soman | 2021 |
Intramuscularly administered A1 adenosine receptor agonists as delayed treatment for organophosphorus nerve agent-induced Status Epilepticus.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Anticonvulsants; Brain; Deoxyadenosines; Disease Models, Animal; Drug Administration Schedule; Injections, Intramuscular; Male; Neuroprotective Agents; Norbornanes; Rats, Sprague-Dawley; Sarin; Soman; Status Epilepticus; Time Factors | 2021 |